NASDAQ:FATE - Fate Therapeutics, Inc.
$18.97
 $0.64
+3.49%
4:00PM EDT
2019-05-24
Fate Therapeutics, Inc. (Fate Therapeutics) is a clinical-stage biopharmaceutical company. The Company is engaged in development of programmed cellular immunotherapies for cancer and immune disorders. The Company's cell therapy pipeline consists of immuno-oncology programs, including cancer immunotherapies derived from engineered induced pluripotent cells, and immuno-regulatory programs, including hematopoietic cell immunotherapies for protecting the immune system of patients undergoing hematopoietic cell transplantation and for suppressing autoimmunity. Its lead clinical program is ProTmune, which is a programmed immuno-regulatory cell therapy. The Company programs immune cells, such as CD34+ cells, Natural Killer (NK) cells and T cells, by utilizing its cell programming approach. Its adoptive cell therapy programs are based on the Company's ex vivo cell programming approach, which it applies to modulate the therapeutic function and direct the fate of immune cells. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  FATE     avg for
industry  
  avg for
sector  
42 stocks weight:  79. 66   0. 00   0. 00  
42 stocks rank:  1. 55 K 4. 42 K 4. 42 K
# analyst opinions:  7. 00   2. 00   2. 00  
mean recommendation:  1. 50   2. 50   2. 50  

quick ratio:  6. 30   4. 77   4. 77  
current ratio:  6. 40   4. 86   4. 86  

target price low:  19. 00   14. 94   14. 94  
target price avg:  21. 00   21. 91   21. 91  
target price high:  24. 00   28. 88   28. 88  
1-yr high:  19. 55   22. 10   22. 10  
last close:  18. 97   21. 57   21. 57  
50-day avg:  17. 39   19. 21   19. 21  
200-day avg:  14. 92   15. 43   15. 43  
1-yr low:  8. 75   11. 51   11. 51  
volume:  1. 00 M 7. 22 K 7. 22 K
50-day avg volume:  701. 37 K 11. 60 K 11. 60 K
200-day avg volume:  713. 89 K 9. 48 K 9. 48 K

1-day return:  3. 49 % 1. 48 % 1. 48 %
this week return:  1. 23 % 8. 64 % 8. 64 %
12-wk return:  14. 62 % 43. 48 % 43. 48 %
52-wk return:  80. 18 % 26. 43 % 26. 43 %

enterprise value (EV):  1. 13 B 625. 52 M 625. 58 M
market cap:  1. 24 B 10020. 31 Q 10020. 30 Q
EBITDA:  -72. 13 M 264. 09   4. 25 K
enterprise multiple (EV/EBITDA):  -15. 72   0. 00   0. 00  
enterprise/revenue (EV/R):  178. 69   0. 00   0. 00  
total revenue:  6. 35 M 621. 35   20. 51 K
total debt:  42. 62 M 687. 38   8. 99 K
debt/equity:  29. 22   0. 55   0. 55  
net income (common):  -72. 22 M 127. 96   2. 24 K

shares outstanding:  65. 19 M 30. 69 M 30. 69 M
shares:  52. 74 M 24. 61 M 24. 61 M
shares short:  9. 58 M 138. 34 K 138. 35 K
shares short prior month:  8. 30 M 144. 84 K 144. 84 K
short ratio:  15. 81   9. 69   9. 69  
short % of float:  27. 96 % 0. 00 % 0. 00 %
total cash/share:  2. 81   0. 00   0. 00  
total cash:  183. 03 M 350. 59   3. 09 K
free cash flow:  -29. 83 M 185. 71   2. 61 K
operating cash flow:  -43. 59 M 240. 38   3. 12 K

book value:  2. 24   6. 32   6. 32  
price/book:  8. 47   3. 41   3. 41  
gross profits:  -51. 28 M 34. 62 M 34. 64 M
operating margins:  -1157. 96 % -0. 00 % -0. 00 %
EBITDA margins:  0. 00 % 2157. 19 % 2157. 19 %
profit margins:  0. 00 % 1950. 54 % 1950. 54 %
gross margins:  0. 00 % 92. 77 % 92. 77 %

1-yr max volatility:  17. 68 % --- ---
1-yr mean volatility:  0. 30 % 0. 20 % 0. 20 %

1-yr EPS:  -1. 22   3. 00   3. 00  
forward EPS:  -1. 19   -1. 96   -1. 96  
P/E:  -15. 56   7. 18   7. 18  
forward P/E:  -15. 75   -10. 34   -10. 34  
PE/G:  -0. 10   9. 74 B 9. 74 B
growth:  156. 50 % 0. 00 % 0. 00 %
earnings high:  -0. 18   -0. 50   -0. 50  
earnings avg:  -0. 30   -0. 50   -0. 50  
earnings low:  -0. 34   -0. 50   -0. 50  
revenue high:  2. 00 M 5. 57 M 5. 58 M
revenue avg:  1. 20 M 5. 57 M 5. 58 M
revenue low:  150. 00 K 5. 57 M 5. 58 M
return on assets:  -29. 23 % 38. 37 % 38. 37 %
return on equity:  -68. 51 % 72. 45 % 72. 45 %
revenue growth:  156. 50 % 0. 00 % 0. 00 %
revenue/share:  0. 11   0. 00   0. 00  

beta (1yr vs S&P500):  2. 07   1. 22   1. 22  
sharpe (1yr):  1. 04   0. 84   0. 84  

held % insiders:  2. 29 % 0. 00 % 0. 00 %
held % institutions:  96. 71 % 9. 00 % 9. 00 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-05-24 : FATE
.      4.355 =         4.355 :: INITIAL WEIGHT
.  + 138.311 =       142.667 :: inverse volume-to-price addition
.   + 34.115 =       176.782 :: spline projection addition
.    x 8.437 =      1491.432 :: 13 weeks' performance factor
.    x 1.683 =      2510.422 :: one-year gains+dividend factor
.    x 1.281 =       3216.47 :: industry recommendation factor
.    x 2.927 =      9413.003 :: company recommendation factor
.    x 3.142 =     29571.822 :: EV/R factor
.    x 0.708 =     20928.865 :: return on assets factor
.    x 0.315 =      6590.081 :: return on equity factor
.    x 2.341 =     15425.169 :: revenue growth factor
.    x 2.684 =     41394.044 :: current ratio factor
.     x 1.09 =     45131.858 :: quick ratio factor
.    x 1.031 =     46537.294 :: short ratio factor
.    x 1.096 =     50982.616 :: price-to-book factor
.    x 2.834 =     144504.18 :: debt-to-equity factor
.    x 1.513 =    218660.872 :: 5-day avg > 200-day avg
.    x 1.326 =    290010.198 :: 5-day avg > 50-day avg
.    x 1.166 =     338152.61 :: 50-day avg > 200-day avg
.    x 2.165 =    732171.649 :: P/E factor
.    x 1.781 =   1303843.864 :: PE/G factor
.    x 1.365 =   1779125.809 :: beta factor
.    x 1.042 =   1853933.363 :: sharpe factor
.    x 1.049 =   1945406.602 :: target low factor
.    x 1.109 =   2157537.283 :: target mean factor
.    x 1.022 =     2204198.7 :: target high factor
.    x 1.756 =   3870629.285 :: industry 2-weeks return factor
.    x 0.992 =   3840263.477 :: "drift" penalty 2 days ago
.    x 0.997 =   3828079.192 :: "drift" penalty 5 days ago
.    / 4.909 =    779791.862 :: overall "drift" factor
.    x 0.823 =    641901.786 :: largest single-day jump factor
.    x 1.001 =     642611.53 :: factor hist industry gain for week 20
.   cubeRoot =        86.294 :: reduced to standardize
.    - 6.638 =        79.656 :: add/subtract for investor sentiment
.                     79.656 :: FINAL WEIGHT for NASDAQ:FATE


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org